Medicare Update: Millions Will See GLP-1 Costs Plummet to $50 Per Month
Summary
Starting July 1, Medicare will launch the GLP-1 Bridge program to help millions of seniors afford weight-loss drugs at a reduced cost of about $50 per month. This program runs until the end of 2027 and aims to make important medications more accessible by lowering their high prices for eligible Medicare recipients.Key Facts
- The Medicare GLP-1 Bridge program begins July 1 and lasts until December 31, 2027.
- It caps out-of-pocket costs for certain weight-loss drugs at about $50 per month.
- These medications include Wegovy, Foundayo, and Zepbound, originally for diabetes but used for weight loss.
- Medicare did not previously cover weight-loss drugs, partly due to federal rules.
- The program is for Medicare Part D or Medicare Advantage members with a doctor’s prescription and prior approval.
- Payments under this program do not count toward Medicare deductibles or out-of-pocket limits.
- Access after 2027 depends on future changes to Medicare policies.
- Patients enroll through their healthcare providers who submit medical information to Medicare.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.